Browsing by Author Kumaran, Raani-Yogeeta

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2014Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonBooth, David; Brilot-Turville, Fabienne; Dale, Russell; Kumaran, Raani-Yogeeta; Mathey, Emily; Merheb, V.; Pathmanandavel, Karrnan; Ramanathan, Sudarshini; Sinmaz, Nese; Tantsis, Esther; Wienholt, Louise; Clark, Damien; Guillemin, Giles; Lim, Chai K; Prelog, Kristina; Western Clinical School: Westmead Millennium Institute; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Childrens Medical Research Ins; Central Clinical School: Medicine; Childrens Hospital Westmead: Paediatrics & Child Health; Physics; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Childrens Medical Research Ins; Central Clinical School: MedicineAntibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton, Neurology: Neuroimmunology and Neuroinflammation, vol.2014, 1, 2014,pp 1-10
2017N-glycosylation of human sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is essential for stability, secretion and activityJessup, Wendy; Kockx, Maaike; Kritharides, Leonard; Kumaran, Raani-Yogeeta; Traini, Mathew; Thaysen-Andersen, M; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Children's Hospital Westmead: Childrens Medical Research Ins; Concord Clinical School: ANZAC Research InstituteN-glycosylation of human sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is essential for stability, secretion and activity, Biochemical Journal, vol.474, 7, 2017,pp 1071-1092